Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-07-20

FDA Approved: KYPROLIS — Original Application (Onyx Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved KYPROLIS (carfilzomib) in its original application for the treatment of multiple myeloma in patients who have received at least one prior thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kyprolis (carfilzomib)

Snippet

ORIG AP for KYPROLIS (CARFILZOMIB)